New Research Poster Presentation 4.28
A Phase-2 Pharmacokinetic Study of a Modified Release Formulation of Dextroamphetamine Following Evening Administration to Adolescents and Children With ADHD
Friday, October 24, 2014 9:30 AM
Declan Quinn, BA, FRCPC, Saskatoon Centre for Patient-Oriented Research, University of Saskatchewan, Royal University Hospital, Saskatoon, SK, Canada
Twyla Bode, RN, Saskatoon Centre for Patient-Oriented Research, Royal University Hospital, Saskatoon, SK, Canada
Norberto J. DeSousa, MA, Ironshore Pharmaceuticals & Development, Inc., Grand Cayman, Cayman Islands
Bev Incledon, PhD, Ironshore Pharmaceuticals & Development, Inc., Grand Cayman, Cayman Islands
Albert Agro, PhD, Ironshore Pharmaceuticals & Development, Inc., Grand Cayman, Cayman Islands
Angus McLean, PhD, Ironshore Pharmaceuticals & Development, Inc., Grand Cayman, Cayman Islands
